The role of radiotherapy in lung cancer: Where is the evidence?
Author:
- 1 May 2007
- journal article
- review article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 83 (2) , 203-213
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patientsAnnals of Oncology, 2006
- 1119 ORAL Continuous hyperfractionated accelerated radiotherapy — weekend less (CHARTWEL) versus conventionally fractionated (CF) radiotherapy in non-small-cell lung cancer (NSCLC): first results of a phase III randomised multicentre trial (ARO 97-1)European Journal of Cancer Supplements, 2005
- Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapyRadiotherapy and Oncology, 2005
- Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and ImplicationsJournal of Clinical Oncology, 2000
- Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung CarcinomaJournal of Clinical Oncology, 1999
- Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete RemissionNew England Journal of Medicine, 1999
- A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trialRadiotherapy and Oncology, 1999
- Formation of DNA Adducts by the Anticancer Drug Carboplatin: Different Nucleotide Sequence Preferences in Vitro and in CellsBiochemistry, 1995
- Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol.Journal of Clinical Oncology, 1995